Delivery Order SPE2DB24D2010-SPE2DB25FZZJ6

Award Date 6/4/25
Potential Completion Date 6/5/25
Potential Value $6.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,030.20 and an ultimate completion date of January 14, 2025. The contract provides for the delivery of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a medical product used for various healthcare applications. This contract award is part of a larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,618.45, is for the supply of EUFLEXXA 20 MG/2 ML SYRINGE 2ML, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of May 8, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $21,102.07 and runs through February 10, 2025. It is for the delivery of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a medical product used in healthcare settings. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,987.28 contract is for the delivery of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a medical product used in the treatment of various medical conditions. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 31, 2024. Amerisourcebergen holds a significant...
This federal contract award, valued at $1,545.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a medical product, with a completion date of June 18, 2025. The contract is a Firm Fixed Price Delivery Order, which is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,851.06, is a Firm Fixed Price Delivery Order for the supply of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML. The contract has an ultimate completion date of April 14, 2025. This award is part of AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a $1,666.80 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a medical product, with a period of performance through April 14, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,459.59, is for the delivery of EUFLEXXA 20 MG/2 ML SYRINGE 2ML, a medical product, to support military healthcare programs. The contract has an ultimate completion date of February 21, 2024 and was awarded on February 20, 2024. This delivery order is part of a larger...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EUFLEXXA 20 MG/2 ML SYRINGE 2ML, a medical product used for various healthcare needs. The contract has a ceiling value of $8,674.70 and is a Firm Fixed Price Delivery Order. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $3,576.64, is for the delivery of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML medical supplies. The award is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
  • SPE2DB24D2010
    Indefinite Delivery Contract
  • SPE2DB24D2010-SPE2DB25FZZJ6
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of EUFLEXXA 1% 20 MG/2 ML SYRINGE 2ML, a medical product, with a firm fixed price ceiling value of $6,317.62. The contract has an ultimate completion date of June 5, 2025. This award is not set-aside and was competitively awarded. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.

Generated 9/3/25, 10:05 AM